Clinical Trials Browser

Phase 3 × Breast Neoplasms, Male × Everolimus × Clear all

NCT01674140 2026-02-10

e3

Phase 3 Active not recruiting

1,939 enrolled 15 charts

Breast Neoplasms, Breast Neoplasms, Male